RAGE and Soluble RAGE: Potential Therapeutic Targets for Cardiovascular Diseases

Receptor for advanced glycation end-products (RAGE) is known to be involved in microvascular complications in diabetes. RAGE is also profoundly associated with macrovascular complications in diabetes through regulation of atherogenesis, angiogenic response, vascular injury, and inflammatory response...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Koyama, Hidenori, Yamamoto, Hiroshi, Nishizawa, Yoshiki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: ScholarOne 2007
Gaiak:
In Overview
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2017106/
https://ncbi.nlm.nih.gov/pubmed/17932553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/2007-00087.Koyama
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak